
LOCUS       NP_003045                514 aa            linear   PRI 04-JUL-2020
DEFINITION  synaptic vesicular amine transporter [Homo sapiens].
ACCESSION   NP_003045
VERSION     NP_003045.2
DBSOURCE    REFSEQ: accession NM_003054.6
KEYWORDS    RefSeq; MANE Select.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 514)
  AUTHORS   Georgantzi K, Tsolakis AV, Jakobson A, Christofferson R, Janson ET
            and Grimelius L.
  TITLE     Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1
            and 2 Are Expressed in Neuroblastoma
  JOURNAL   Endocr. Pathol. 30 (3), 173-179 (2019)
   PUBMED   31317476
  REMARK    GeneRIF: SV2 was highly expressed in neuroblastoma (NB) and can
            thus be useful marker in NB diagnostics. VMAT1 and VMAT2 were also
            expressed in NB but similar to syn less reliable as tumor markers.
REFERENCE   2  (residues 1 to 514)
  AUTHORS   Randesi M, van den Brink W, Levran O, Blanken P, van Ree JM, Ott J
            and Kreek MJ.
  TITLE     VMAT2 gene (SLC18A2) variants associated with a greater risk for
            developing opioid dependence
  JOURNAL   Pharmacogenomics 20 (5), 331-341 (2019)
   PUBMED   30983500
  REMARK    GeneRIF: Nominal associations were indicated for 20 variants in six
            genes including an experiment-wise significant association from the
            combined effect of three SLC18A2 SNPs (rs363332, rs363334 and
            rs363338) with heroin dependence (pfinal = 0.047).
REFERENCE   3  (residues 1 to 514)
  AUTHORS   Cho SS, Christopher L, Koshimori Y, Li C, Lang AE, Houle S and
            Strafella AP.
  TITLE     Decreased pallidal vesicular monoamine transporter type 2
            availability in Parkinson's disease: The contribution of the
            nigropallidal pathway
  JOURNAL   Neurobiol. Dis. 124, 176-182 (2019)
   PUBMED   30471418
  REMARK    GeneRIF: Study shows decreased pallidal vesicular monoamine
            transporter type 2 availability in Parkinson's disease. Findings
            showed dopamine terminals in the globus pallidus may be
            differentially vulnerable in different stages of the disease.
REFERENCE   4  (residues 1 to 514)
  AUTHORS   Hu T, Chen Y, Ou R, Wei Q, Cao B, Zhao B, Wu Y, Song W, Chen X and
            Shang HF.
  TITLE     Association analysis of polymorphisms in VMAT2 and TMEM106B genes
            for Parkinson's disease, amyotrophic lateral sclerosis and multiple
            system atrophy
  JOURNAL   J. Neurol. Sci. 377, 65-71 (2017)
   PUBMED   28477711
  REMARK    GeneRIF: This study showed that in Chinese patient population, 'GG'
            of rs363371 in VMAT2 may reduce the risk for ALS.
REFERENCE   5  (residues 1 to 514)
  AUTHORS   Li Q, Yan Z, Kuang Y, Zhou X, Jin L, He L, Sun X, Tao T and Wang L.
  TITLE     Genetic variations in the 3'-untranslated region of SLC18A2 are
            associated with serum FSH concentration in polycystic ovary
            syndrome patients and regulate gene expression in vitro
  JOURNAL   Hum. Reprod. 31 (9), 2150-2157 (2016)
   PUBMED   27354380
  REMARK    GeneRIF: We found a novel association between two genetic variants
            in SLC18A2 and FSH levels in PCOS patients. These findings might
            indicate a novel regulatory mechanism in follicular development and
            maturation in PCOS.
REFERENCE   6  (residues 1 to 514)
  AUTHORS   Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V,
            Raisman-Vozari R, Krejci E, Massoulie J and Gasnier B.
  TITLE     Biochemistry and molecular biology of the vesicular monoamine
            transporter from chromaffin granules
  JOURNAL   J. Exp. Biol. 196, 251-262 (1994)
   PUBMED   7823026
  REMARK    Review article
REFERENCE   7  (residues 1 to 514)
  AUTHORS   Erickson JD and Eiden LE.
  TITLE     Functional identification and molecular cloning of a human brain
            vesicle monoamine transporter
  JOURNAL   J. Neurochem. 61 (6), 2314-2317 (1993)
   PUBMED   8245983
REFERENCE   8  (residues 1 to 514)
  AUTHORS   Peter D, Finn JP, Klisak I, Liu Y, Kojis T, Heinzmann C, Roghani A,
            Sparkes RS and Edwards RH.
  TITLE     Chromosomal localization of the human vesicular amine transporter
            genes
  JOURNAL   Genomics 18 (3), 720-723 (1993)
   PUBMED   7905859
REFERENCE   9  (residues 1 to 514)
  AUTHORS   Surratt CK, Persico AM, Yang XD, Edgar SR, Bird GS, Hawkins AL,
            Griffin CA, Li X, Jabs EW and Uhl GR.
  TITLE     A human synaptic vesicle monoamine transporter cDNA predicts
            posttranslational modifications, reveals chromosome 10 gene
            localization and identifies TaqI RFLPs
  JOURNAL   FEBS Lett. 318 (3), 325-330 (1993)
   PUBMED   8095030
REFERENCE   10 (residues 1 to 514)
  AUTHORS   Lesch KP, Gross J, Wolozin BL, Murphy DL and Riederer P.
  TITLE     Extensive sequence divergence between the human and rat brain
            vesicular monoamine transporter: possible molecular basis for
            species differences in the susceptibility to MPP+
  JOURNAL   J. Neural Transm. Gen. Sect. 93 (1), 75-82 (1993)
   PUBMED   8373557
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DB458870.1, L23205.1,
            AL391988.14 and BQ416859.1.
            On Feb 9, 2004 this sequence version replaced NP_003045.1.
            
            Summary: This gene encodes an transmembrane protein that functions
            as an ATP-dependent transporter of monoamines, such as dopamine,
            norepinephrine, serotonin, and histamine. This protein transports
            amine neurotransmitters into synaptic vesicles. Polymorphisms in
            this gene may be associated with schizophrenia, bipolar disorder,
            and other neurological/psychiatric ailments. [provided by RefSeq,
            Jun 2018].
            
            Sequence Note: This RefSeq record was created from transcript and
            genomic sequence data to make the sequence consistent with the
            reference genome assembly. The genomic coordinates used for the
            transcript record were based on transcript alignments.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: SRR1803617.68719.1,
                                           SRR1803615.245761.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA1968540, SAMEA2142348
                                           [ECO:0000348]
            ##Evidence-Data-END##
            
            ##RefSeq-Attributes-START##
            MANE Ensembl match     :: ENST00000644641.2/ ENSP00000496339.1
            RefSeq Select criteria :: based on single protein-coding transcript
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..514
                     /organism="Homo sapiens"
                     /db_xref="taxon:9606"
                     /chromosome="10"
                     /map="10q25.3"
     Protein         1..514
                     /product="synaptic vesicular amine transporter"
                     /note="vesicle monoamine/H+ antiporter; monoamine
                     neurotransmitter transporter; vesicle monoamine
                     transporter type 2; vesicular amine transporter 2; solute
                     carrier family 18 (vesicular monoamine transporter),
                     member 2; synaptic vesicle monoamine transporter, brain;
                     synaptic vesicle amine transporter, brain"
                     /calculated_mol_wt=55582
     Site            21..41
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            84
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q05940.2)"
     Site            91
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255; propagated from
                     UniProtKB/Swiss-Prot (Q05940.2)"
     Site            130..150
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            160..180
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            190..210
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            220..242
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            249..271
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            292..311
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            329..352
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            358..378
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            390..410
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            415..435
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            441..462
                     /site_type="transmembrane region"
                     /note="propagated from UniProtKB/Swiss-Prot (Q05940.2)"
     Site            511
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000250|UniProtKB:Q01827; propagated from
                     UniProtKB/Swiss-Prot (Q05940.2)"
     Site            513
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0000250|UniProtKB:Q01827; propagated from
                     UniProtKB/Swiss-Prot (Q05940.2)"
     CDS             1..514
                     /gene="SLC18A2"
                     /gene_synonym="PKDYS2; SVAT; SVMT; VAT2; VMAT2"
                     /coded_by="NM_003054.6:123..1667"
                     /db_xref="CCDS:CCDS7599.1"
                     /db_xref="GeneID:6571"
                     /db_xref="HGNC:HGNC:10935"
                     /db_xref="MIM:193001"
ORIGIN      
        1 malselalvr wlqesrrsrk lilfivflal lldnmlltvv vpiipsylys ikheknatei
       61 qtarpvhtas isdsfqsifs yydnstmvtg natrdltlhq tatqhmvtna savpsdcpse
      121 dkdllnenvq vgllfaskat vqlitnpfig lltnrigypi pifagfcimf vstimfafss
      181 syaflliars lqgigsscss vagmgmlasv ytddeergnv mgialgglam gvlvgppfgs
      241 vlyefvgkta pflvlaalvl ldgaiqlfvl qpsrvqpesq kgtplttllk dpyiliaags
      301 icfanmgiam lepalpiwmm etmcsrkwql gvaflpasis yligtnifgi lahkmgrwlc
      361 allgmiivgv silcipfakn iygliapnfg vgfaigmvds smmpimgylv dlrhvsvygs
      421 vyaiadvafc mgyaigpsag gaiakaigfp wlmtiigiid ilfaplcffl rsppakeekm
      481 ailmdhncpi ktkmytqnni qsypigedee sesd
//

